Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Valéa, Innocent, Adjei, Samuel, Usuf, Effua, Traore, Ousmane, Ansong, Daniel, Tinto, Halidou, Owusu Boateng, Harry, Leach, Amanda, Mwinessobaonfou Some, Athanase, Buabeng, Patrick, Vekemans, Johan, Nana, Louis Arnaud, Kotey, Amos, Vandoolaeghe, Pascale, Ouedraogo, Florence, Sambian, David, Lievens, Marc, Tahita, Marc Christian, Rettig, Theresa, Jongert, Erik, Lompo, Palpouguini, Idriss, Ali, Borys, Dorota, Ouedraogo, Sayouba, Prempeh, Frank, Habib, Md Ahsan, Schuerman, Lode, Sorgho, Hermann, Agbenyega, Tsiri
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037440/
https://ncbi.nlm.nih.gov/pubmed/29630438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1442996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars